Browse by Academic Unit (A-Z)

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Creators Name | Item Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | M | N | O | P | R | S | T | V | Z
Number of items at this level: 66.

A

Abignano, G, Blagojevic, J, Bissell, L-A orcid.org/0000-0002-2789-4652 et al. (16 more authors) (2019) European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis. Rheumatology, 58 (2). key271. pp. 254-259. ISSN 1462-0324

Alase, AA, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Vital, EM orcid.org/0000-0003-1637-4755 et al. (3 more authors) (2015) IFNλ Stimulates MxA Production in Human Dermal Fibroblasts via a MAPK-Dependent STAT1-Independent Mechanism. The Journal of Investigative Dermatology, 135 (12). pp. 2935-2943. ISSN 0022-202X

Alfuraih, AM orcid.org/0000-0002-4655-7248, O'Connor, P, Tan, AL orcid.org/0000-0002-9158-7243 et al. (4 more authors) (2019) Muscle shear wave elastography in idiopathic inflammatory myopathies: a case-control study with MRI correlation. Skeletal Radiology. ISSN 0364-2348

Alfuraih, AM orcid.org/0000-0002-4655-7248, Tan, AL orcid.org/0000-0002-9158-7243, O’Connor,, P et al. (2 more authors) (2019) The effect of ageing on shear wave elastography muscle stiffness in adults. Aging Clinical and Experimental Research. ISSN 1594-0667

Aydin, SZ, Gunal, EK, Ozata, M et al. (4 more authors) (2017) Six-joint ultrasound in rheumatoid arthritis: a feasible approach for implementing ultrasound in remission. Clinical and Experimental Rheumatology, 35 (5). pp. 853-856. ISSN 0392-856X

Aydin, SZ, Pay, S, Inanc, N et al. (4 more authors) (2017) Which joints and why do rheumatologists scan in rheumatoid arthritis by ultrasonography? A real life experience. Clinical and Experimental Rheumatology, 35 (3). pp. 508-511. ISSN 0392-856X

B

Backhouse, MR orcid.org/0000-0003-0056-8467, Hensor, EMA orcid.org/0000-0002-5245-4755, White, D et al. (3 more authors) (2013) Concurrent validation of activity monitors in patients with rheumatoid arthritis. Clinical Biomechanics, 28 (4). pp. 473-479. ISSN 0268-0033

Baraliakos, X, Conaghan, PG orcid.org/0000-0002-3478-5665, D'Agostino, M-A et al. (5 more authors) (2019) Imaging in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and osteoarthritis: An international viewpoint on the current knowledge and future research priorities. European Journal of Rheumatology, 6 (1). pp. 37-45. ISSN 2147-9720

Brown, S orcid.org/0000-0002-1840-3786, Everett, CC orcid.org/0000-0002-9788-840X, Naraghi, K et al. (8 more authors) (2018) Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT. Health Technology Assessment, 22 (34). ISSN 1366-5278

Burska, AN, Thu, A, Parmar, R et al. (7 more authors) (2019) Quantifying circulating Th17 cells by qPCR: potential as diagnostic biomarker for Rheumatoid Arthritis. Rheumatology. ISSN 1462-0324 (In Press)

Bykerk, VP, Burmester, GR, Combe, BG et al. (4 more authors) (2019) Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis. Rheumatology International. ISSN 0172-8172

Bykerk, VP, Burmester, GR, Combe, BG et al. (4 more authors) (2018) On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis. Rheumatology International, 38 (12). pp. 2225-2231. ISSN 0172-8172

C

Coates, LC orcid.org/0000-0002-4756-663X, Lubrano, E, Perrotta, FM et al. (3 more authors) (2019) What Should Be the Primary Target of “Treat to Target” in Psoriatic Arthritis? Journal of Rheumatology, 46 (1). pp. 38-42. ISSN 0315-162X

D

Duquenne, L, Gul, H and Emery, P (2019) Safety evaluation of Adalimumab in immune-mediated inflammatory disorders: a rheumatological point of view. Expert opinion on drug safety, 8 (1). ISSN 1474-0338

E

El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Md Yusof, MY orcid.org/0000-0003-3131-9121, Hensor, E orcid.org/0000-0002-5245-4755 et al. (3 more authors) (2016) Surface Tetherin Is A Novel Cell-Specific Biomarker for Interferon Response in Systemic Lupus Erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 546.

El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Psarras, A, Yusof, MYM et al. (8 more authors) (2018) Publisher Correction: A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. Scientific Reports, 8. ARTN 14846. ISSN 2045-2322

Emery, P, Blanco, R, Maldonado Cocco, J et al. (8 more authors) (2017) Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis. RMD Open, 3 (1). e000410. ISSN 2056-5933

Emery, P orcid.org/0000-0002-7429-8482, Burmester, GR, Bykerk, VP et al. (4 more authors) (2019) Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study. RMD Open, 5 (1). e000840. ISSN 2056-5933

Emery, P, Mankia, K and Nam, JL (2017) Individuals at risk of rheumatoid arthritis – The evolving story. Best Practice & Research Clinical Rheumatology, 31 (1). pp. 1-2. ISSN 1521-6942

Emery, P, Pope, JE, Kruger, K et al. (4 more authors) (2018) Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review. Advances in Therapy, 35 (10). pp. 1535-1563. ISSN 0741-238X

Emery, P, Rondon, J, Parrino, J et al. (8 more authors) (2018) Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis. Rheumatology. key361. ISSN 1462-0324

Emery, P orcid.org/0000-0002-7429-8482, Van Keep, M, Beard, S et al. (6 more authors) (2018) Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK. PharmacoEconomics, 36 (8). pp. 1015-1027. ISSN 1170-7690

F

Fent, G, Mankia, K, Erhayiem, B et al. (10 more authors) (2019) First cardiovascular MRI study in individuals at-risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody mediated role for accelerated atherosclerosis. Annals of the Rheumatic Diseases. ISSN 0003-4967

Fisher, BA, Emery, P orcid.org/0000-0002-7429-8482, Pitzalis, C et al. (2 more authors) (2019) Response to: Can ultrasound of the major salivary glands assess histopathological changes induced by treatment with rituximab in primary Sjögren’s syndrome? Annals of the Rheumatic Diseases, 78 (4). e28-e28. ISSN 0003-4967

G

Garcia-Montoya, L, Gul, H and Emery, P (2018) Recent advances in ankylosing spondylitis: understanding the disease and management. F1000Research, 7.

Gillespie, J, Ross, RL, Corinaldesi, C et al. (7 more authors) (2018) Transforming Growth Factor β Activation Primes Canonical Wnt Signaling Through Down-Regulation of Axin-2. Arthritis & Rheumatology, 70 (6). pp. 932-942. ISSN 2326-5191

Gossec, L, Kirkham, B, Rahman, P et al. (4 more authors) (2018) Clinically Meaningful Improvement in Health-Related Quality of Life and the Association with Disease Activity in Psoriatic Arthritis after Treatment with Guselkumab: Results from a Randomized Placebo-Controlled Phase II Clinical Trial. In: Arthritis and Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL, USA. Wiley .

H

Hackett, KL, Davies, K, Tarn, JR et al. (31 more authors) (2019) Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome. RMD Open. ISSN 2056-5933 (In Press)

Hensor, EMA orcid.org/0000-0002-5245-4755, McKeigue, P, Buch, MH orcid.org/0000-0002-8962-5642 et al. (20 more authors) (2018) Validity of a2-component imaging-derived disease activity score (2C-DAS28) for improved assessment of synovitis in early rheumatoid arthritis. In: Rheumatology. British Society for Rheumatology Annual Conference 2018, 01-03 May 2018, Liverpool, United Kingdom. Oxford University Press .

Hensor, EMA orcid.org/0000-0002-5245-4755, McKeigue, P, Ling, SF et al. (20 more authors) (2019) Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis. Rheumatology. kez049. ISSN 1462-0324

Howard Tripp, N, Tarn, J, Natasari, A et al. (29 more authors) (2016) Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines. RMD Open, 2 (2). e000282.

I

Inomata, H, Bissell, L-A orcid.org/0000-0002-2789-4652, Naraghi, K et al. (6 more authors) (2016) FRI0130 Efficacy of A Comprehensive Cardiovascular Risk Reduction Patient Education Programme in Patients with Early Inflammatory Arthritis Following A Treat To Target Therapeutic Regime. In: Annals of the Rheumatic Diseases. EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 475.

J

Jani, M, Dixon, WG, Kersley-Fleet, L et al. (7 more authors) (2017) Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA. RMD Open, 3 (1). e000314. ISSN 2056-5933

Jani, M, Isaacs, JD, Morgan, AW orcid.org/0000-0003-1109-624X et al. (5 more authors) (2017) High Frequency of Anti-Drug Antibodies and Association of Random Drug Levels with Efficacy in Certolizumab Pegol Treated Patients with Rheumatoid Arthritis: Results from the BRAGGSS Cohort. Annals of the Rheumatic Diseases, 76 (1). pp. 208-213. ISSN 0003-4967

K

Kay, J, Dörner, T, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2019) Clinical trial and 'real-world' data support switching from a bio-originator to its biosimilar. Annals of the Rheumatic Diseases. ISSN 0003-4967

M

Mackie, SL, Pease, CT, Fukuba, E et al. (5 more authors) (2015) Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids. Annals of the Rheumatic Diseases, 72 (12). pp. 2188-2192. ISSN 0003-4967

Mahmoud, K, Zayat, A, Edwards, CJ et al. (5 more authors) (2016) An Evaluation of Clinical Outcome Measures for Musculoskeletal Lupus Using Ultrasound as A Gold Standard: Table 1. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ PUblishing Group , p. 556.

Mahmoud, K, Zayat, AS, Yusof, Y et al. (4 more authors) (2019) Responsiveness of clinical and ultrasound outcome measures in musculoskeletal systemic lupus erythematosus. Rheumatology. key422. ISSN 1462-0324

Mankia, K, D'Agostino, MA and Emery, P (2018) Response to: 'Ultrasound findings in palindromic rheumatism' by Sanmarti et al. Annals of the Rheumatic Diseases. ISSN 0003-4967

Mankia, K, D'Agostino, MA, Rowbotham, E et al. (12 more authors) (2019) MRI Inflammation of the Hand Interosseous Tendons occurs in anti-CCP positive at-risk individuals and may precede the development of clinical synovitis. Annals of the Rheumatic Diseases. ISSN 0003-4967

Mankia, K, D'Agostino, MA, Wakefield, RJ orcid.org/0000-0001-5352-8683 et al. (4 more authors) (2019) Identification of a distinct imaging phenotype may improve the management of palindromic rheumatism. Annals of the Rheumatic Diseases, 78 (1). pp. 43-50. ISSN 0003-4967

Mathews, RJ, Robinson, JI orcid.org/0000-0001-5425-7520, Battellino, M et al. (17 more authors) (2014) Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Annals of the Rheumatic Diseases, 73 (6). pp. 1202-1210. ISSN 0003-4967

Md Yusof, MY orcid.org/0000-0003-3131-9121, Britton, J, Hensor, EM orcid.org/0000-0002-5245-4755 et al. (4 more authors) (2017) Laser doppler imaging: an objective outcome measure for assessment of cutaneous lupus erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , pp. 1019-1020.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Candelier, JB, Dass, S et al. (3 more authors) (2016) Validation of B Cell Depletion as A Predictor of Clinical Response and Efficacy of Retreatment of Non-Response in Rheumatoid Arthritis. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 731.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Cassamoali, H, Rawstron, AC et al. (4 more authors) (2016) Humanized Anti-CD20 Antibodies Improve Depletion and Response in Systemic Lupus Erythematosus Patients with Resistance to Rituximab: Results from the First 100 Patients at a Single Centre. In: Rheumatology. Rheumatology 2016, 26-28 Apr 2016, Glasgow, UK. Oxford University Press , i46-i47.

Md Yusof, MY orcid.org/0000-0003-3131-9121, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Psarras, A et al. (6 more authors) (2017) Prediction of connective tissue disease in an at-risk cohort using a novel interferon stimulated gene expression score. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 91.

Md Yusof, MY orcid.org/0000-0003-3131-9121, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Psarras, A et al. (4 more authors) (2016) Incomplete and Systemic Lupus Erythematosus Reveal A Different Pattern of Interferon-Stimulated Genes Up-Regulation. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , pp. 285-286.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Iqbal, K, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2016) Efficacy and Safety of Rituximab in Patients with Rheumatoid Arthritis-Related Bronchiectasis (RA-BR): Results from A Multicentre Cohort. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 996.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Shaw, D, El-Sherbiny, YM orcid.org/0000-0003-4791-3475 et al. (3 more authors) (2017) Predicting and managing primary and secondary non-response to rituximab using b-cell biomarkers in systemic lupus erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 869.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Shaw, D, Rawstron, A et al. (2 more authors) (2016) Validation of Highly Sensitive Flow Cytometry as A Biomarker for Rituximab in Sle: A Rationale for More Intensive Treatment To Improve Clinical Outcomes. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 296.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, McElvenny, D et al. (5 more authors) (2017) Risk factors for severe infection and rationale for immunoglobulin monitoring during rituximab treatment in autoimmune rheumatic diseases. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 987.

Mease, P, Coates, LC, Helliwell, PS et al. (14 more authors) (2018) Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial. The Lancet, 392 (10162). pp. 2367-2377. ISSN 0140-6736

Mease, PJ, Palmer, JB, Hur, P et al. (7 more authors) (2019) Utilization of the validated Psoriasis Epidemiology Screening Tool (PEST) to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross‐sectional analysis from the US‐based Corrona Psoriasis Registry. Journal of the European Academy of Dermatology and Venereology. ISSN 0926-9959

Mohamed, AAA, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Hensor, EM orcid.org/0000-0002-5245-4755 et al. (6 more authors) (2016) Type I Interferon Activity Is Associated with Mucocutaneous but Not Musculoskeletal Disease Activity in Systemic Lupus Erythematosus:. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 547.

N

Nam, JL, Villeneuve, E, Hensor, EM orcid.org/0000-0002-5245-4755 et al. (13 more authors) (2014) Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study). Annals of the Rheumatic Diseases, 73 (1). pp. 75-85. ISSN 0003-4967

O

Orr, C, Vieira-Sousa, E, Boyle, DL et al. (26 more authors) (2017) Synovial tissue research: a state-of-the-art review. Nature Reviews Rheumatology, 13 (8). pp. 463-475. ISSN 1759-4790

P

Peterfy, C, DiCarlo, J, Emery, P et al. (7 more authors) (2019) Use of Magnetic Resonance Imaging to Support Dose Selection in a Phase II Trial of Baricitinib Combined with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis. Journal of Rheumatology. ISSN 0315-162X

R

Romão, VC, Vital, EM orcid.org/0000-0003-1637-4755, Fonseca, JE et al. (1 more author) (2017) Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis? Arthritis Research & Therapy, 19 (1). 239. ISSN 1478-6354

S

Savage, L, Goodfield, M, Horton, L et al. (6 more authors) (2019) Regression of peripheral subclinical enthesopathy in therapy-naïve patients treated with Ustekinumab for moderate-to-severe chronic plaque psoriasis: A Fifty‐Two–Week, Prospective, Open‐Label Feasibility Study. Arthritis and Rheumatology, 71 (4). pp. 626-631. ISSN 2326-5191

Savic, S orcid.org/0000-0001-7910-0554, Ouboussad, L, Dickie, LJ et al. (10 more authors) (2014) TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes. Journal of Autoimmunity, 50. pp. 59-66. ISSN 0896-8411

Smolen, JS, Pangan, AL, Emery, P orcid.org/0000-0002-7429-8482 et al. (9 more authors) (2019) A Phase 3 Randomised, Placebo-controlled, Double-Blind Study of Upadacitinib as Monotherapy in Patients with Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: SELECT-MONOTHERAPY. The Lancet. ISSN 0140-6736 (In Press)

T

Tan, AL orcid.org/0000-0002-9158-7243, Buch, M orcid.org/0000-0002-8962-5642, O'Reilly, D et al. (5 more authors) (2017) 21st century state of rheumatoid arthritis management in the uk. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology, 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 786.

Tanaka, Y, McInnes, IB, Taylor, PC et al. (10 more authors) (2018) Characterization and changes of lymphocyte subsets in baricitinib-treated patients with rheumatoid arthritis: an integrated analysis. Arthritis and Rheumatology, 70 (12). pp. 1923-1932. ISSN 2326-5191

V

Vital, EM orcid.org/0000-0003-1637-4755, Wittmann, M orcid.org/0000-0003-2328-4926, Edward, S et al. (5 more authors) (2015) Brief report: Responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus. Arthritis and Rheumatology, 67 (6). pp. 1586-1591. ISSN 2326-5191

Z

Zayat, AS, Mahmoud, K, Md Yusof, MY orcid.org/0000-0003-3131-9121 et al. (4 more authors) (2016) A Prospective Study To Assess Responsiveness of Clinical and Ultrasound Outcome Measures for Musculoskeletal Sle. In: Annals of the Rheumatic Diseases. Annual European Conference of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 549.

Zayat, AS, Mahmoud, K, Yusof, MYM et al. (8 more authors) (2019) Defining inflammatory musculoskeletal manifestations in systemic lupus erythematosus. Rheumatology, 58 (2). key277. pp. 304-312. ISSN 1462-0324

This list was generated on Fri Apr 26 03:47:58 2019 BST.